Get the Stockscreener App
1.10
0.92%
0.01
After Hours:
1.07
-0.03
-2.73%
Novabay Pharmaceuticals Inc stock is traded at $1.10, with a volume of 115.99K.
It is up +0.92% in the last 24 hours and down -19.12% over the past month.
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets non-antibiotic and anti-infective products for the eye care market in the United States, China, and internationally. It offers Avenova, a prescription product for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye; NeutroPhase for wound care market; CelleRx for the aesthetic dermatology market; Aganocide compounds patented synthetic molecules for use against bacteria, viruses, and fungi; auriclosene irrigation solution for urology; and intelli-Case, a device for soft and rigid gas permeable contact lenses. NovaBay Pharmaceuticals, Inc. has collaboration and license agreement with Virbac to develop auriclosene, a proprietary compound for veterinary markets. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.
See More
Previous Close:
$1.09
Open:
$1.08
24h Volume:
115.99K
Relative Volume:
0.02
Market Cap:
$6.41M
Revenue:
$4.75M
Net Income/Loss:
$-7.83M
P/E Ratio:
5.0528
EPS:
0.2177
Net Cash Flow:
$-7.24M
1W Performance:
-12.70%
1M Performance:
-19.12%
6M Performance:
+87.52%
1Y Performance:
+45.50%
1-Day Range:
$1.07
$1.14
1-Week Range:
$1.07
$1.27
52-Week Range:
$0.46
$4.44
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Name
Novabay Pharmaceuticals Inc
Sector
Industry
Phone
510-899-8800
Address
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.10 | 6.55M | 4.75M | -7.83M | -7.24M | 0.2177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-19 | Initiated | Ladenburg Thalmann | Buy |
| Jul-06-18 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-17 | Reiterated | Laidlaw | Buy |
| Jun-05-17 | Initiated | ROTH Capital | Buy |
| Mar-27-17 | Initiated | Laidlaw | Buy |
| Feb-06-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-07-16 | Downgrade | Maxim Group | Buy → Hold |
| Dec-14-15 | Reiterated | Maxim Group | Buy |
| Apr-30-15 | Resumed | Maxim Group | Buy |
| Mar-06-13 | Initiated | Ascendiant Capital Markets | Strong Buy |
| Jan-03-08 | Initiated | Dawson James | Speculative Buy |
View All
Novabay Pharmaceuticals Inc Stock (NBY) Latest News
Will NovaBay Pharmaceuticals Inc. (B9P0) stock benefit from commodity supercycleWeekly Trade Summary & Community Consensus Picks - newser.com
Heatmap analysis for NovaBay Pharmaceuticals Inc. and competitorsWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Is NovaBay Pharmaceuticals Inc. stock undervalued vs historical averages2025 Price Momentum & Consistent Growth Stock Picks - newser.com
Why analysts recommend NovaBay Pharmaceuticals Inc. (B9P0) stockLayoff News & Verified Short-Term Plans - newser.com
Why NovaBay Pharmaceuticals Inc. stock fits value portfolios2025 Sector Review & Real-Time Market Sentiment Reports - newser.com
Is NovaBay Pharmaceuticals Inc. (B9P0) stock positioned for digital growth eraRate Hike & Fast Momentum Stock Entry Tips - newser.com
Will NovaBay Pharmaceuticals Inc. stock benefit from commodity pricesJuly 2025 Movers & Technical Pattern Based Buy Signals - newser.com
Published on: 2025-11-04 02:43:49 - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock announce a stock splitJuly 2025 Reactions & Free High Accuracy Swing Entry Alerts - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock outperform Dow JonesJuly 2025 Institutional & Technical Confirmation Alerts - newser.com
Top chart patterns to watch in NovaBay Pharmaceuticals Inc.Weekly Trend Recap & Daily Oversold Bounce Ideas - newser.com
Statistical indicators supporting NovaBay Pharmaceuticals Inc.’s strength2025 Momentum Check & Expert Curated Trade Ideas - newser.com
Will NovaBay Pharmaceuticals Inc. stock recover faster than industry2025 Analyst Calls & Free Real-Time Market Sentiment Alerts - newser.com
How NovaBay Pharmaceuticals Inc. stock performs in interest rate cycles2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com
NovaBay Pharmaceuticals Inc. stock trendline breakdown2025 Price Momentum & Fast Momentum Entry Tips - newser.com
Price momentum metrics for NovaBay Pharmaceuticals Inc. explained2025 Volatility Report & Intraday High Probability Alerts - newser.com
How NovaBay Pharmaceuticals Inc. stock moves on employment dataIPO Watch & Free Growth Oriented Trading Recommendations - newser.com
Will breakout in NovaBay Pharmaceuticals Inc. lead to full recovery2025 Market Trends & Scalable Portfolio Growth Methods - newser.com
Why NovaBay Pharmaceuticals Inc. stock is trending among retail traders2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
What margin trends mean for NovaBay Pharmaceuticals Inc. stockWeekly Trend Summary & Target Return Focused Picks - newser.com
Is NovaBay Pharmaceuticals Inc. stock attractive for retirement portfoliosWeekly Trend Report & AI Enhanced Trading Alerts - newser.com
Is NovaBay Pharmaceuticals Inc. stock undervalued after correctionProduct Launch & Free Reliable Trade Execution Plans - newser.com
How analysts revise price targets for NovaBay Pharmaceuticals Inc. (B9P0) stock2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - newser.com
Is NovaBay Pharmaceuticals Inc. stock undervalued historicallyWeekly Volume Report & Weekly Market Pulse Updates - newser.com
What technical signals suggest for NovaBay Pharmaceuticals Inc. stockJuly 2025 Breakouts & High Yield Equity Trading Tips - newser.com
Is NovaBay Pharmaceuticals Inc. (B9P0) stock a top dividend aristocrat candidateMarket Movement Recap & Community Driven Trade Alerts - newser.com
Can NovaBay Pharmaceuticals Inc. stock withstand economic slowdownQuarterly Portfolio Summary & AI Enhanced Execution Alerts - newser.com
Novabay Pharmaceuticals Inc Stock (NBY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):